• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Natrol Highlights Published Clinical Treatment Protocol Recommending Red Clover Isoflavones As a Safe Alternative to Hormone Replacement Therapy

Posted on: Friday, 14 September 2007, 09:00 CDT

A recently published clinical treatment protocol recommends supplementation with red clover isoflavones, a key ingredient in Promensil®, for women experiencing menopause symptoms.* This protocol was developed by physicians and other healthcare professionals from the United States, United Kingdom, Canada, Australia, and The Netherlands, and recommends supplementation with red clover isoflavones as a complementary therapy for treating mild-to-moderate menopause symptoms, as well as for treating severe symptoms when hormone replacement therapy (HRT) is contraindicated.1†

According to Michael Yatcilla, Ph.D., Vice President of Research and Development for Natrol, "We have long had confidence in the significant body of clinical research indicating Promensil® provides benefits for menopausal women by offering a unique isoflavone ratio that is a safe alternative to HRT. Promensil® can help relieve the frequency and severity of hot flashes, and promote breast and heart health, as well as emotional well-being."†

Dr. Yatcilla added, "The design of a clinical treatment protocol by practicing OB/GYN physicians adds new support recommending the use of Promensil®. These clinicians, who are concerned about the realities of patient compliance, safety and therapeutic value, have found that Promensil® represents a valuable addition to any physician's menopause treatment options."†

Promensil® was developed by Novogen Limited, an Australian biotechnology company, which launched the product in Australia in 1997. Today, Promensil® has a global presence in countries in Europe, Asia, Africa, and North America. In addition, Novogen holds an extensive portfolio of patents related to isoflavones and has conducted one of the largest and most comprehensive isoflavone clinical testing programs in the world.

Natrol, Inc. (NASDAQ: NTOL), headquartered in Chatsworth, CA, has a portfolio of health and wellness brands representing quality nutritional supplements, functional herbal teas, and sports nutrition products. Established in 1980, Natrol's portfolio of brands includes: Natrol®, MRI, Prolab®, Laci Le Beau®, Promensil®, Trinovin®, Nu Hair®, and Shen Min®. The company also manufactures supplements for its own brands and on behalf of third parties.

Natrol distributes products nationally through more than 54,000 retailers, as well as internationally in over 40 other countries through distribution partners and subsidiaries in the UK and Hong Kong. Natrol's dedication to quality is evidenced by its commitment to high manufacturing standards, earning the company an "A" rating from the Natural Products Association's Good Manufacturing Practices ("GMP") Certification Program--a designation achieved by less than ten percent of U.S. nutrition companies. For more information, visit www.Natrol.com.

About Novogen

Novogen Limited (Nasdaq: NVGN) is an Australian biotechnology company which has patented isoflavone technology for the treatment and prevention of degenerative diseases and disorders. Over the past ten years, Novogen has conducted the largest and most comprehensive isoflavone clinical testing programs in the world. Novogen is involved in drug discovery and product development for disorders that are commonly associated with aging and coordinates an international clinical research and development program with external collaborators, hospitals and universities. For more information, visit www.novogen.com.

1 Nachtigall LE, Baber RJ, Barentsen R, et al. Complementary and hormonal therapy for vasomotor symptom relief: a conservative clinical approach. J Obstet Gynaecol Can. 2006;28:279-289.

*A copy of the recently published clinical treatment protocol recommending supplementation with red clover isoflavones (a key ingredient in Promensil®) for women experiencing menopause symptoms is available upon request.

†These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

(Additional Information / Interviews Available)

Source: Business Wire

More News in this Category